JangoBio advancing to next stage of animal testing

Researchers with JangoBio, a Madison-based startup developing stem cell therapies, are set to begin testing on companion animals such as dogs within the next two months.   Bill Kohl, chief operating officer for JangoBio, says this marks a step forward in the company’s journey to bring its anti-aging therapy to market, starting with non-agricultural animals.   “Things look promising,” Koh...